08.25.25 -- 2025 2H Trends: Regulations, Precision Medicine, Oncology Investment

The evolving pharmaceutical landscape demands continuous regulatory adaptation to safeguard patient safety and ensure compliance.

AI is transforming clinical trials by streamlining patient recruitment and screening. Discover how advanced technologies are accelerating research and bringing life-saving treatments to market faster.

Thorough characterization is key to unlocking the potential of antibody-based therapeutics. Leveraging a CDMO's extensive capabilities and expertise can allow you to navigate the development landscape.

Eurofins PSS provided full-time, benefit-rich staffing to replace inequitable temporary roles, creating long-term value, equity, and continuity for a major biopharma client.

Discover how innovative systems streamline antibody development to enhance target-binding analysis, optimize therapeutic selection, and accelerate clinical success with precision tools.

Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.